| Literature DB >> 25514968 |
Amy Hsu1, Jessamyn Conell-Price, Irena Stijacic Cenzer, Catherine Eng, Alison J Huang, Kathy Rice-Trumble, Sei J Lee.
Abstract
BACKGROUND: Diabetes mellitus is a potent risk factor for urinary incontinence. Previous studies of incontinence in patients with diabetes have focused on younger, healthier patients. Our objective was to characterize risk factors for urinary incontinence among frail older adults with diabetes mellitus in a real-world clinical setting.Entities:
Mesh:
Year: 2014 PMID: 25514968 PMCID: PMC4274753 DOI: 10.1186/1471-2318-14-137
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Figure 1Inclusion and exclusion criteria for participants and measurements; ESRD = End -stage renal disease.
Baseline characteristics of participants by urinary incontinence status, N = 447
| Characteristic | Number of persons, N | Never incontinent, N | Seldom incontinent, N | Often incontinent, N | p-value |
|---|---|---|---|---|---|
|
| 447 | 249 (56%) | 125 (28%) | 73 (16%) | |
|
| 78 (±8.2) | 80 (±8.1) | 81 (±8.0) | 0.961 | |
|
| |||||
| <75 | 127 | 88 (70%) | 27 (21%) | 12 (9%) | 0.003 |
| 75-80 | 101 | 52 (52%) | 34 (34%) | 15 (15%) | |
| 80-85 | 118 | 64 (54%) | 28 (24%) | 26 (22%) | |
| >85 | 101 | 45 (56%) | 36 (36%) | 20 (16%) | |
|
| |||||
| Asian | 290 | 168 (58%) | 73 (25%) | 49 (17%) | 0.364 |
| White | 58 | 25 (43%) | 21 (36%) | 12 (21%) | |
| African | 35 | 19 (54%) | 11 (31%) | 5 (15%) | |
| American/Other | |||||
| Latino | 64 | 37 (58%) | 20 (31%) | 7 (11%) | |
|
| |||||
| Male | 154 | 98 (64%) | 40 (26%) | 16 (10%) | 0.018 |
| Female | 293 | 151 (51%) | 85 (29%) | 57 (19%) | |
|
| |||||
| Independent | 254 | 173 (68%) | 61 (24%) | 20 (8%) | 0.000 |
| Dependentb | 188 | 75 (40%) | 63 (34%) | 50 (27%) | |
|
| |||||
| Independent | 317 | 204 (64%) | 82 (26%) | 31 (10%) | 0.000 |
| Dependentb | 127 | 45 (35%) | 42 (33%) | 40 (32%) | |
|
| |||||
| Absent | 228 | 184 (64%) | 71 (25%) | 33 (11%) | 0.000 |
| Present | 159 | 65 (41%) | 54 (34%) | 40 (25%) | |
|
| |||||
|
| |||||
| No | 336 | 188 (56%) | 91 (27%) | 57 (17%) | 0.679 |
| Yes | 111 | 61 (55%) | 34 (31%) | 16 (14%) | |
|
| |||||
|
| |||||
| Absent | 329 | 187 (57%) | 87 (26%) | 55 (17%) | 0.287 |
| Present | 110 | 59 (54%) | 37 (34%) | 14 (13%) | |
|
| |||||
|
| 7.7 (7.5-7.9) | 7.6 (7.3-7.8) | 7.7 (7.4-8.0) | 0.645 | |
| <7 | 163 | 87 (53%) | 53 (33%) | 23 (14%) | 0.382 |
| 7-7.9 | 152 | 82 (54%) | 42 (28%) | 28 (18%) | |
| 8-8.9 | 69 | 46 (67%) | 13 (19%) | 10 (14%) | |
| ≥9 | 63 | 34 (54%) | 17 (27%) | 12 (19%) | |
|
| |||||
| None | 272 | 157 (58%) | 70 (38%) | 45 (17%) | 0.527 |
| Oral Medications | 133 | 73 (55%) | 39 (29%) | 21 (16%) | |
| Insulin | 42 | 19 (45%) | 16 (38%) | 7 (17%) | |
|
| |||||
|
| |||||
| Absent | 200 | 106 (53%) | 57 (29%) | 37 (19%) | 0.460 |
| Present | 247 | 143 (58%) | 68 (28%) | 36 (15%) | |
|
| |||||
| Absent | 299 | 165 (55%) | 80 (27%) | 54 (18%) | 0.338 |
| Present | 148 | 84 (57%) | 45 (30%) | 19 (13%) | |
|
| |||||
| Absent | 384 | 216 (56%) | 107 (28%) | 61 (16%) | 0.784 |
| Present | 63 | 33 (52%) | 18 (29%) | 12 (19%) | |
|
| |||||
| Absent | 336 | 180 (54%) | 103 (31%) | 53 (16%) | 0.088 |
| Present | 111 | 69 (62%) | 22 (20%) | 20 (18%) | |
aN = 5 with missing observations.
bPartially or fully dependent.
cN = 3 with missing observations.
dN = 6 with missing observations.
Multivariate analysis of factors associated with urinary incontinence
| Characteristic | Never vs. Seldom/often incontinent | Never vs. often incontinent | ||
|---|---|---|---|---|
| Unadjusted OR (95% CI) | Adjusted aOR (95% CI) | Unadjusted OR (95% CI) | Adjusted aOR (95% CI) | |
| Non-diabetes related factors | ||||
|
| ||||
|
| ||||
| <75 | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| 75-80 | 1.79 (1.37-2.35) | 1.57 (1.17-2.11) | 1.38 (0.94-2.01) | 1.18 (0.73-1.89) |
| 80-85 | 2.61 (1.92-3.56) | 2.11 (1.51-2.95) | 2.84 (1.87-4.31) | 2.35 (1.44-3.84) |
| >85 | 4.75 (3.36-6.71) | 3.13 (2.15-4.56) | 3.76 (2.38-5.93) | 2.29 (1.34-3.92) |
|
| ||||
| Asian | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| White | 1.59 (0.99-2.55) | 2.15 (1.28-3.59) | 1.67 (0.93-3.01) | 1.80 (0.93-3.48) |
| African | 1.29 (0.73-2.28) | 2.12 (1.14-3.93) | 1.76 (0.90-3.44) | 2.43 (1.16-5.08) |
| American/Other | ||||
| Latino | 0.99 (0.64-1.53) | 1.08 (0.67-1.75) | 0.94 (0.51-1.70) | 0.91 (0.49-1.70) |
|
| ||||
| Male | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Female | 1.55 (1.13-2.14) | 1.27 (0.91-1.78) | 1.38 (0.90-2.11) | 0.95 (0.61-1.49) |
|
| ||||
|
| ||||
| Independent | 1.00 (Reference) | 1.00(Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Dependentb | 2.34 (1.98-2.76) | 1.48 (1.19-1.84) | 2.89 (2.31-3.61) | 1.92 (1.37-2.67) |
|
| ||||
| Independent | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Dependentb | 2.84 (2.35-3.44) | 2.02 (1.58-2.58) | 3.72 (2.92-4.75) | 2.78 (1.99-3.89) |
|
| ||||
| Absent | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Present | 1.67 (1.40-1.99) | 1.41 (1.15-1.73) | 1.71 (1.37-2.13) | 1.85 (1.39-2.46) |
|
| ||||
|
| ||||
| No | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Yes | 1.24 (0.93-1.65) | 0.81 (0.57-1.15) | 0.94 (0.66-1.36) | 0.64 (0.39-1.04) |
|
| ||||
|
| ||||
| Absent | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Present | 0.91 (0.64-1.29) | 0.97 (0.67-1.41) | 0.78 (0.48-1.25) | 0.75 (0.45-1.23) |
|
| ||||
|
| ||||
| <7 | 1.05 (0.89-1.23) | 1.01 (0.84-1.22) | 0.86 (0.71-1.05) | 0.75 (0.57-1.00) |
| 7-7.9c | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| 8-8.9 | 0.76 (0.63-0.91) | 0.81 (0.65-1.01) | 0.86 (0.69-1.08) | 0.94 (0.69-1.29) |
| ≥9 | 0.69 (0.55-0.87) | 0.85 (0.65-1.11) | 0.85 (0.64-1.12) | 1.10 (0.74-1.63) |
|
| ||||
| None | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Oral Medications | 1.66 (1.30-2.13) | 1.81 (1.33-2.45) | 1.50 (1.11-2.03) | 1.79 (1.17-2.75) |
| Insulin | 2.30 (1.58-3.37) | 2.62 (1.67-4.13) | 2.33 (1.53-3.54) | 3.41 (1.88-6.21) |
|
| ||||
|
| ||||
| Absent | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Present | 0.93 (0.68-1.26) | 0.95 (0.68-1.33) | 0.76 (0.51-1.13) | 0.73 (0.46-1.14) |
|
| ||||
| Absent | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Present | 0.82 (0.60-1.13) | 1.00 (0.71-1.43) | 0.70 (0.46-1.09) | 0.68 (0.42-1.10) |
|
| ||||
| Absent | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Present | 1.68 (1.08-2.61) | 1.31 (0.81-2.10) | 2.30 (1.38-3.83) | 2.33 (1.35-4.02) |
|
| ||||
| Absent | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Present | 0.72 (0.51-1.02) | 0.73 (0.49-1.08) | 1.05 (0.68-1.65) | 1.43 (0.87-2.36) |
aAdjusted for age, gender, Asian race, depression, cognitive impairment, use of thiazide or loop diuretics, diabetic medication use, diabetic complications (neurological, renal, ophthalmologic, peripheral vascular, other), and dependence in transferring and/or ambulating.
bPartially or fully dependent.
cHemoglobin A1c level of 7% to 7.9% was used as the reference since the AGS “Guideline for improving the care of older persons with diabetes mellitus” recommends <8% as appropriate target for glycemic control for “frail elders with limited life expectancy [24]”.